Decision-Making and Purchasing Process for Specific Active Pharmaceutical Ingredients (APIs) and Drug Outlook Driving the Demand Globally

CHALLENGE

A tier 1 private equity firm engaged a global strategy consulting firm to conduct a commercial due diligence (CDD) project focused on the decision-making and purchasing processes for specific Active Pharmaceutical Ingredients (APIs) and the global outlook driving drug demand. The goal was to provide a comprehensive analysis of market dynamics and procurement trends to inform strategic investment decisions.

BTHT APPROACH

After a detailed initial consultation with the consulting firm and a thorough understanding of the project’s objectives, the BTHT team identified and connected with key industry experts. They reached out to Procurement and Market Access Directors from leading pharmaceutical companies known for their expertise in API sourcing and drug market dynamics. The BTHT team organized and facilitated a series of expert calls, ensuring each discussion was insightful and free of technical issues.

OUTCOME

The BTHT team’s strategic approach provided the private equity firm with valuable insights from top Procurement and Market Access Directors. The expert calls delivered critical information on the decision-making and purchasing processes for APIs, including current trends, challenges, and factors influencing global drug demand. This detailed analysis supported the consulting firm in delivering a comprehensive and actionable assessment, helping the client make well-informed investment decisions in the pharmaceutical sector.